Schema-Root.org logo

 

  cross-referenced news and research resources about

 Baxter pharmaceutical company

Schema-Root.org logo
images:  google   yahoo YouTube
spacer

updated Thu. November 21, 2019

-
Baxter International Inc. (BAX) is an interesting player in the Healthcare space, with a focus on Medical Instruments & Supplies. The stock has been active on the tape, currently trading at $66.67, up from yesterday's close by 1.76%. Given the stock's recent action, it seemed like a good time to take a closer ...
Baxter International Inc. (NYSE:BAX) market capitalization at present is $36.43B at the rate of $65.52 a share. The firm's price-to-sales ratio was noted 3.54 in contrast with an overall industry average of 7.52. Most of the active traders and investors are keen to find ways to compare the value of stocks.

Baxter International logo Oakbrook Investments LLC reduced its position in shares of Baxter International Inc (NYSE:BAX) by 50.9% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 17,280 shares of the medical instruments supplier's stock ...
US stocks brushed aside their first wobble of the year and got back to setting records on Thursday. Energy stocks led the way after the price of oil touched its highest level since 2014. The gains for indexes marked a return to calm, after a whiff of nervousness wafted through markets a day earlier as interest ...
Shares of Baxter International Inc (BAX) is moving on volatility today -0.12% or -0.08 from the open. The NYSE listed company saw a recent bid of 68.38 on 535273 volume. Looking at the current landscape of the equity market, investors may be doing some bargain hunting for stocks to add to the portfolio.
Baxter International (NYSE: BAX) and Lombard Medical (OTCMKTS:EVARF) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, earnings, dividends ...

Investors sentiment increased to 0.97 in Q3 2017. Its up 0.05, from 0.92 in 2017Q2. It is positive, as 38 investors sold Baxter International Inc. shares while 300 reduced holdings. 76 funds opened positions while 253 raised stakes. 439.80 million shares or 0.96% less from 444.08 million shares in 2017Q2 ...
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) shares are down more than -4.66% this year and recently decreased -4.11% or -$2.69 to settle at $62.76. Baxter International Inc. (NYSE:BAX), on the other hand, is up 5.86% year to date as of 01/10/2018. It currently trades at $68.43 and has returned 0.26% ...
Investment company Rowland & Co Investment Counsel buys BB&T Corp, Baxter International Inc, Bank of New York Mellon Corp, Fluor Corp, Abbott Laboratories, Corning Inc, Phillips 66, Simmons First National Corp, sells Bed Bath & Beyond Inc, General Electric Co, Berkshire Hathaway Inc, Biogen Inc ...
Baxter International (NYSE:BAX) initiates the U.S. launch of the Arisure Closed System Transfer Device, a multi-component product that prevents contaminants from entering an intravenous (IV) medication delivery system and the release of hazardous substances out of the system during drug preparation ...
Baxter International (BAX) is expected to announce its 4Q17 and fiscal 2017 earnings results on or around January 30, 2018. The company announced stellar 3Q17 earnings results on October 25, 2017. Year-over-year, Baxter International expects to report 4Q17 sales growth of 4%–5% and ...
On January 4, 2018, Baxter International was trading at a 52-week high of $68.86 per share, ending the day at $68.41 per share. The company has seen significant momentum in its stock price recently. The company was trading at a 52-week low of $44.56 a year ago, on January 5, 2017. BAX stock has ...
On January 4, 2018, Baxter International was trading at a 52-week high of $68.86 per share, ending the day at $68.41 per share. The company has seen significant momentum in its stock price recently. The company was trading at a 52-week low of $44.56 a year ago, on January 5, 2017. BAX stock has ...
Baxter International (NYSE: BAX) and Globus Medical (NYSE:GMED) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, earnings, risk and ...
Before we dive into any analysis we simply note that Baxter International Inc (NYSE:BAX) risk is actually priced pretty low by the option market as of right now. We'll detail it below -- but that's the lede -- the option market is reflecting a sort of risk malaise, for now, an IV30 of 15.75% versus the IV30 of the S&P ...
Baxter International Inc. (NYSE:BAX) closed at $64.90 a share in the latest session and the stock value rose almost 46.37% since the beginning of this year. The company has managed to keep price to sales ratio of 3.38 against an industry average of 7.58. The price to sales ratio is the ratio of the market ...
Baxter International logo News headlines about Baxter International (NYSE:BAX) have been trending somewhat positive recently, Accern Sentiment reports. Accern identifies positive and negative news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of ...

Baxter International Inc. (NYSE:BAX) shares are up more than 46.64% this year and recently increased 0.46% or $0.3 to settle at $65.02. C. R. Bard, Inc. (NYSE:BCR), on the other hand, is up 48.41% year to date as of 12/26/2017. It currently trades at $333.41 and has returned -0.12% during the past week.
Baxter International Inc. (BAX) is an interesting player in the Healthcare space, with a focus on Medical Instruments & Supplies. The stock has been active on the tape, currently trading at $65.02, up from yesterday's close by 0.46%. Given the stock's recent action, it seemed like a good time to take a closer ...
Baxter International Inc (NYSE:BAX) is a $35.7 billion in market value constituent of the Health Care Equipment & Supplies GICS industry group where the stock's current Portfolio Grader score places it 9 among the 161 companies in this industry group, putting it in the top decile. BAX is ranked among the ...
Feb 1 (Reuters) - Baxter International Inc on Thursday forecast 2018 earnings largely ahead of analysts' estimates and said it would continue to be active on the acquistion front and repurchase more shares through the year. The hospital products maker, whose fourth-quarter profit beat analysts' ...
(RTTNews) - Baxter International Inc. (BAX) revealed a profit for its fourth quarter that rose compared to the same period last year. The company said its bottom line advanced to $354 million, or $0.64 per share. This was higher than $312 million, or $0.57 per share, in last year's fourth quarter. Analysts had ...
When Baxter International, Inc. (NYSE:BAX) reported its third-quarter results in October, the main story focused on the company's cost-cutting efforts. The medical products supplier's earnings growth was much higher than its revenue growth as a result of those efforts. Baxter announced its fourth-quarter and ...
Good morning, ladies and gentlemen, and welcome to Baxter International's Fourth Quarter 2017 Earnings Conference Call. Your lines will remain in a listen-only mode, until the question-and-answer segment of today's call. [Operator Instructions] As a reminder, this call is being recorded by Baxter and is ...
Mallinckrodt (NYSE:MNK) inks an agreement with Baxter International (NYSE:BAX) to sell hemostasis products RECOTHROM Thrombin topical (Recombinant) and PREVELEAK ... CEO Mark Trudeau says, "Mallinckrodt is transforming itself to become a top-performing specialty pharmaceutical company.
Baxter International Inc. (NYSE:BAX) market capitalization at present is $35.27B at the rate of $64.72 a share. The firm's price-to-sales ratio was noted 3.38 in contrast with an overall industry average of 7.55. Most of the active traders and investors are keen to find ways to compare the value of stocks.
Northpointe Cap Limited Liability Corp stated it has 0.61% of its portfolio in Baxter International Inc. (NYSE:BAX). Hendershot Invests Inc has invested 0.97% in Baxter International Inc. (NYSE:BAX). Cleararc Cap has invested 0.11% of its portfolio in Baxter International Inc. (NYSE:BAX). Sandy Spring ...
Baxter International (NYSE: BAX) and Globus Medical (NYSE:GMED) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and ...
Baxter International logo NorthCoast Asset Management LLC trimmed its position in shares of Baxter International Inc (NYSE:BAX) by 6.0% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 345,912 shares of the medical ...
Before we cover the full analysis we make a quick alert here that Baxter International Inc (NYSE:BAX) has seen its stock price move at a rock bottom low level. We'll go through the details below -- but that's the lede -- the stock has been unusally quiet. If there was a post it note to summarize the stock ...
Baxter International logo American International Group Inc. lessened its holdings in Baxter International Inc. (NYSE:BAX) by 7.5% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 158,714 shares of the medical ...
Baxter International Inc. (NYSE:BAX) market capitalization at present is $34.73B at the rate of $63.72 a share. The firm's price-to-sales ratio was noted 3.34 in contrast with an overall industry average of 7.47. Most of the active traders and investors are keen to find ways to compare the value of stocks.
Investors may be taking a closer look at shares of Baxter International Inc. (NYSE:BAX). Sometimes the stock market can be frustrating, even for ...
Baxter International Inc. (NYSE:BAX) trades at $63.88 having a market capitalization of $35.41 billion. BAX stock price climbed 35.63% over the ...
Baxter International Inc. (NYSE:BAX)'s 0.21% Lead Over A Technical Metric. On the other hand, Baxter International Inc. by far traveled 48.11% ...
Baxter International Inc. (NYSE:BAX) ended its day at $63.88 with the rising stream of -1.71% and its total traded volume was 4.88 million ...
Baxter International (NYSE: BAX) and Transenterix (NYSE:TRXC) are both medical companies, but which is the superior investment? We will ...
Baxter International logo Baxter International Inc. (NYSE:BAX) has received an average rating of “Buy” from the fourteen ratings firms that are ...
Baxter International (NYSE: BAX) and CONMED Corporation (NASDAQ:CNMD) are both large-cap medical companies, but which is the better ...
Checking in on some valuation rankings, Baxter International Inc. (NYSE:BAX) has a Value Composite score of 57. Developed by James ...
Shares of Baxter International Inc (BAX) recently touched $65.10, which places the stock above the Ichimoku cloud, indicating positive ...
Oakbrook Investments LLC's holdings in Baxter International were ... Alps Advisors Inc. raised its position in shares of Baxter International by ...
Baxter International logo Baxter International Inc. (NYSE:BAX) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” ...
Baxter International Inc. (NYSE:BAX) plunged -0.42% with the closing price of $64.20. The overall volume in the last trading session was 1.85 ...
Currently, Baxter International Inc (NYSE:BAX) has a Strong Buy using the Portfolio Grader stock evaluator, which incorporates Louis ...
Baxter International (BAX) updated its fiscal 2017 guidance during the company's 3Q17 earnings release on October 25, 2017. The sales ...
Drug and medical product-maker Baxter International, based in Deerfield, says it expects a near-term shortage of its so-called mini bags, used ...
Good morning, ladies and gentlemen, and welcome to Baxter International's Third Quarter 2017 Earnings Conference Call. Your lines will ...
Baxter International Inc. (BAX) have shown a high EPS growth of 18.40% in the last 5 years and has earnings rose of 24.00% yoy. Analysts have a mean recommendation of 2.60 on this stock (A rating of less than 2 means buy, “hold” within the 3 range, “sell” within the 4 range, and “strong sell” within the 5 ...
Baxter International Inc (NYSE:BAX) is a $35.7 billion in market value constituent of the Health Care Equipment & Supplies GICS industry group where the stock's current Portfolio Grader score places it 9 among the 161 companies in this industry group, putting it in the top decile. BAX is ranked among the ...


 

news and opinion


 


 


 


 


schema-root.org

     baxter
       vaccines

pharmaceutical industry:
     allergan
     ariad
     astrazeneca
     baxter
     eli lilly
     glaxosmithkline
     merck
     mylan
     novartis
     pfizer
     products
     purdue pharma
     research
     takeda
     teva
     upjohn
     valeant